| Premium subsidies, the mandate, and Medicaid expansion: Coverage effects of the Affordable Care Act M Frean, J Gruber, BD Sommers Journal of health economics 53, 72-86, 2017 | 587 | 2017 |
| An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug M Munsell, M Frean, J Menzin, AL Phillips Patient preference and adherence, 55-62, 2016 | 76 | 2016 |
| Disentangling the ACA’s coverage effects—lessons for policymakers M Frean, J Gruber, BD Sommers New England Journal of Medicine 375 (17), 1605-1608, 2016 | 58 | 2016 |
| Medical group structural integration may not ensure that care is integrated, from the patient’s perspective MJ Kerrissey, JR Clark, MW Friedberg, W Jiang, AK Fryer, M Frean, ... Health Affairs 36 (5), 885-892, 2017 | 50 | 2017 |
| Effective leadership of surgical teams: a mixed methods study of surgeon behaviors and functions JL Stone, EL Aveling, M Frean, MC Shields, C Wright, F Gino, TM Sundt, ... The Annals of thoracic surgery 104 (2), 530-537, 2017 | 49 | 2017 |
| Trends in disenrollment and reenrollment within US commercial health insurance plans, 2006-2018 H Fang, M Frean, G Sylwestrzak, B Ukert JAMA Network Open 5 (2), e220320-e220320, 2022 | 24 | 2022 |
| Health reform and coverage changes among Native Americans M Frean, S Shelder, MB Rosenthal, TD Sequist, BD Sommers JAMA internal medicine 176 (6), 858-860, 2016 | 23 | 2016 |
| Real-world bleeding risk among non-valvular atrial fibrillation (NVAF) patients prescribed apixaban, dabigatran, rivaroxaban and warfarin: analysis of electronic health records I Lin, C Masseria, J Mardekian, M Frean, H Phatak, S Kamble, ... European Heart Journal 36, 1084-1084, 2015 | 21 | 2015 |
| Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs M Munsell, M Frean, J Menzin, AL Phillips BMC neurology 17, 1-8, 2017 | 10 | 2017 |
| Patient experiences of integrated care in medicare accountable care organizations and medicare advantage versus traditional fee-for-service M Frean, C Covington, M Tietschert, H Bahadurzada, J So, SJ Singer Medical care 59 (3), 195-201, 2021 | 7 | 2021 |
| Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status CM McDonald, JR Marden, PB Shieh, BL Wong, H Lane, A Zhang, ... Journal of Comparative Effectiveness Research 12 (4), e220190, 2023 | 6 | 2023 |
| Functional and clinical outcomes associated with steroid treatment among non-ambulatory patients with Duchenne muscular dystrophy 1 CM McDonald, OH Mayer, KN Hor, D Miller, N Goemans, EK Henricson, ... Journal of neuromuscular diseases 10 (1), 67-79, 2023 | 6 | 2023 |
| Inhaled nitric oxide in term/late preterm neonates with hypoxic respiratory failure: estimating the financial impact of earlier use GG Konduri, J Menzin, M Frean, T Lee, J Potenziano, J Singer Journal of medical economics 18 (8), 612-618, 2015 | 6 | 2015 |
| Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records data J Menzin, R Preblick, M Friedman, J Menzin, M Frean, WJ Kwong Hospital Practice 42 (4), 59-74, 2014 | 6 | 2014 |
| International reference pricing: a lazy, misguided, bi-partisan plan to lower US drug prices A Basu, PJ Neumann, SD Sullivan Health Affairs Forefront, 2020 | 4 | 2020 |
| An assessment of adherence among multiple sclerosis patients newly initiating treatment with a self-injectable versus oral disease-modifying drug M Munsell, JC Locklear, AL Phillips, M Frean, J Menzin Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), 2015 | 4 | 2015 |
| Differences in patient perceptions of integrated care among black, hispanic, and white Medicare beneficiaries EJ Ling, M Frean, J So, M Tietschert, N Song, C Covington, ... Health Services Research 56 (3), 507-516, 2021 | 3 | 2021 |
| Premium subsidies, the mandate, and Medicaid expansion: Coverage effects of the Affordable Care Act (No. w22213) M Frean, J Gruber, BD Sommers National Bureau of Economic Research. doi 10, w22213, 2016 | 3 | 2016 |
| An Assessment of Adherence among Multiple Sclerosis Patients Newly Initiating Treatment with a Self-Injectable Versus Oral Disease-Modifying Drug (P3. 281) J Locklear, A Phillips, M Munsell, M Frean, J Menzin Neurology 84 (14_supplement), P3. 281, 2015 | 3 | 2015 |
| How Does Cost-Sharing Impact Spending Growth and Cost-Effective Treatments? Evidence from Deductibles C Lucarelli, M Frean, AS Gordon, LM Hua, M Pauly National Bureau of Economic Research, 2020 | 2 | 2020 |
